References
- Bruix, J., Boix, L., Sala, M. & Llovet, J. M. Focus on hepatocellular carcinoma. Cancer Cell 5:215-219 (2004) https://doi.org/10.1016/S1535-6108(04)00058-3
- Farazi, P. A. & DePinho, R. A. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6:674-687 (2006) https://doi.org/10.1038/nrc1934
- de La Coste, A. et al. Somatic mutations of the betacatenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95: 8847-8851 (1998) https://doi.org/10.1073/pnas.95.15.8847
- Pang, A., Ng, I. O., Fan, S. T. & Kwong, Y. L. Clinicopathologic significance of genetic alterations in hepatocellular carcinoma. Cancer Genet Cytogenet 146:8-15 (2003) https://doi.org/10.1016/S0165-4608(03)00103-1
- Satoh, S. et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24:245-250 (2000) https://doi.org/10.1038/73448
- Thorgeirsson, S. S. & Grisham, J. W. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31:339-346 (2002) https://doi.org/10.1038/ng0802-339
- Krebs, D. L. & Hilton, D. J. SOCS: physiological suppressors of cytokine signaling. J Cell Sci 113 (Pt 16):2813-2819 (2000)
- Endo, T. A. et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921-924 (1997) https://doi.org/10.1038/43213
- Naka, T. et al. Structure and function of a new STATinduced STAT inhibitor. Nature 387:924-929 (1997) https://doi.org/10.1038/43219
- Zhang, J. G. et al. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci USA 96:2071-2076 (1999) https://doi.org/10.1073/pnas.96.5.2071
- Emanuelli, B. et al. SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem 275:15985-15991 (2000) https://doi.org/10.1074/jbc.275.21.15985
- Kario, E. et al. Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling. J Biol Chem 280:7038-7048 (2005) https://doi.org/10.1074/jbc.M408575200
- Bayle, J. et al. Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling. J Biol Chem 279:12249-12259 (2004) https://doi.org/10.1074/jbc.M313381200
- Masuhara, M. et al. Cloning and characterization of novel CIS family genes. Biochem Biophys Res Commun 239:439-446 (1997) https://doi.org/10.1006/bbrc.1997.7484
- Bayle, J. et al. The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins. FEBS Lett 580:2609-2614 (2006) https://doi.org/10.1016/j.febslet.2006.03.093
- Mooney, R. A. et al. Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J Biol Chem 276:25889-25893 (2001) https://doi.org/10.1074/jbc.M010579200
- Yoshikawa, H. et al. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 28:29-35 (2001) https://doi.org/10.1038/ng0501-29
- Niwa, Y. et al. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Oncogene 24:6406-6417 (2005) https://doi.org/10.1038/sj.onc.1208788
- Calvisi, D. F. et al. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology 130:1117-1128 (2006) https://doi.org/10.1053/j.gastro.2006.01.006
- Ogata, H. et al. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. Gastroenterology 131:179-193 (2006) https://doi.org/10.1053/j.gastro.2006.04.025
- Liu, L. et al. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res 66:11851-11858 (2006) https://doi.org/10.1158/0008-5472.CAN-06-1377
- Toniato, E. et al. TRIM8/GERP RING finger protein interacts with SOCS-1. J Biol Chem 277:37315-37322 (2002) https://doi.org/10.1074/jbc.M205900200
- Haan, S. et al. Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation. J Biol Chem 278:31972-31979 (2003) https://doi.org/10.1074/jbc.M303170200
- Li, L. et al. Insulin induces SOCS-6 expression and its binding to the p85 monomer of phosphoinositide 3-kinase, resulting in improvement in glucose metabolism. J Biol Chem 279:34107-34114 (2004) https://doi.org/10.1074/jbc.M312672200
- Kamizono, S. et al. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem 276:12530-12538 (2001) https://doi.org/10.1074/jbc.M010074200
- Orr, S. J. et al. CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover. Blood 109:1061-1068 (2007) https://doi.org/10.1182/blood-2006-05-023556
- Orr, S. J. et al. SOCS3 targets Siglec 7 for proteasomal degradation and blocks Siglec 7-mediated responses. J Biol Chem 282:3418-3422 (2007) https://doi.org/10.1074/jbc.C600216200